Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

Market Cap	476.76B
Revenue (ttm)	215.44B
Net Income (ttm)	-33.66B
Shares Out	51.26M
EPS (ttm)	-656.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	645,309
Average Volume	224,382
Open	9,020.00
Previous Close	9,010.00
Day's Range	8,620.00 - 9,040.00
52-Week Range	8,500.00 - 19,850.00
Beta	0.81
RSI	30.22
Earnings Date	Mar 20, 2025

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1962
• Employees: 815
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 019170

Financial Performance

In 2023, KRX:019170's revenue was 200.23 billion, a decrease of -4.33% compared to the previous year's 209.29 billion. Losses were -55.13 billion, 55.8% more than in 2022.